Actinogen Medical (ACW.AX) Stock Price
Actinogen Medical Price
Revenue has compounded at 23.3% per year over the past 17 years to 5.49 M AUD. Actinogen Medical's net margin stands at -268.4%, down from -197.3% several years earlier. Analysts set a median price target of 0.08 AUD, implying 54.0% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Actinogen Medical stock price
Actinogen Medical business model & stock analysis
Frequently asked questions about Actinogen Medical
Analysts currently set an average price target of 0.08 AUD for the Actinogen Medical stock (median: 0.08 AUD), implying +54.0 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Actinogen Medical stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Actinogen Medical share trades at 0.03 EUR (0.05 AUD).
The Actinogen Medical share (ACW.AX) is listed on 3 stock exchanges, including: ASX (ACW.AX), Frankfurt (3AC.F).
The revenue cannot currently be calculated for Actinogen Medical.
The profit of Actinogen Medical is -15.38 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Actinogen Medical is currently -11.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Actinogen Medical stock.
The P/S cannot be calculated for Actinogen Medical currently.
The Eulerpool Quality Score for Actinogen Medical is 2/10.
The ISIN of Actinogen Medical is AU000000ACW3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Actinogen Medical is A0MZH8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Actinogen Medical is ACW.AX. The ticker symbol is used to trade Actinogen Medical shares on the stock exchange.
Actinogen Medical stock
Actinogen Medical Peer Group
Actinogen Medical Ticker
Actinogen Medical FIGI
All fundamentals and in-depth analysis of Actinogen Medical
Our stock analysis for Actinogen Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Actinogen Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.